Alpharma Inc

Material Contracts Filter

EX-10.99
from 10-Q 89 pages Development and License Agreement Between Durect Corporation and Alpharma Ireland Limited Dated as of September 19, 2008
12/34/56
EX-10.98
from 10-Q 19 pages Alpharma Inc. Executive Change in Control Plan Amended and Restated Effective September 1, 2008
12/34/56
EX-10.9.D
from 8-K 2 pages To: Carol A. Wrenn From: Dean Mitchell Regarding: Employment Terms Date: September 1, 2008 This Memo Confirms Your Employment as President, Animal Health of Alpharma Inc. (“Alpharma” or the “Company”), Reporting to Me. the Terms of Your Employment Are Listed Below and in the Plan Documents for Each of the Compensation and Benefits Programs Available to You. (In the Event of Any Inconsistency Between This Memo and the Plan Documents, as May Be Amended From Time to Time, the Plan Documents Will Govern). Effective Date: September 1, 2008. Annual Base Salary: Your Annual Base Salary Shall Continue at Your Current Rate of $414,000/Year. Executive Allowance: Your Executive Allowance Will Remain at $28,600 Per Year, Paid Bi-Weekly. Short Term Incentive Plan (Stip): Your Target Bonus Will Remain at 50% of Your Base Salary. Severance Plan and Change of Control Plan
12/34/56
EX-10.8.C
from 8-K 4 pages To: Dr. Ronald Warner From: Dean Mitchell Regarding: Employment Terms Date: September 1, 2008 This Memo Confirms Your Employment as Executive Vice President and Chief Scientific Officer of Alpharma Inc. (“Alpharma” or the “Company”), Reporting to Me. the Terms of Your Employment Are Listed Below and in the Plan Documents for Each of the Compensation and Benefits Programs Available to You. (In the Event of Any Inconsistency Between This Memo and the Plan Documents, as May Be Amended From Time to Time, the Plan Documents Will Govern). Effective Date: September 1, 2008. Annual Base Salary: Your Annual Base Salary Shall Continue at Your Current Rate of $441,000/Year. Executive Allowance: Your Executive Allowance Will Remain at $28,600 Per Year, Paid Bi-Weekly. Short Term Incentive Plan (Stip): Your Target Bonus Will Remain at 50% of Your Base Salary. Severance Plan and Change of Control Plan
12/34/56
EX-10.2
from 8-K ~5 pages Alpharma Inc. Employee Stock Purchase Plan March 11, 2008
12/34/56
EX-10.1
from 8-K ~20 pages Alpharma Inc. 2003 Omnibus Incentive Compensation Plan February 22, 2008
12/34/56
EX-10.1
from 10-Q 1 page First Amendment to License Agreement
12/34/56
EX-10.1
from 8-K ~5 pages Amended Alpharma Inc. Short-Term Incentive Plan
12/34/56
EX-10
from 10-K ~5 pages Attention: This Revised Performance Based Restricted Stock Unit Award Shall Not Become Effective Unless and Until It Is "Accepted" by the Employee in the Manner Described in Section 1(b) Below. Revised Performance Based Restricted Stock Unit Award Agreement This Agreement Replaces the Prior Agreement Dated March 28, 2007
12/34/56
EX-10
from 10-K ~10 pages Alpharma Inc. Supplemental Savings Plan (Amended and Restated Effective January 1, 2008) Alpharma Inc. Supplemental Savings Plan
12/34/56
EX-10
from 10-K ~5 pages A. L. Pharma Inc. Supplemental Pension Plan Section 1 Introduction Section 2 Benefits
12/34/56
EX-10
from 10-K ~10 pages Alpharma Inc. Change in Control Plan Amended and Restated Effective January 25, 2008 Section I - Definitions
12/34/56
EX-10
from 10-K ~5 pages Alpharma Inc. Severance Plan Amended and Restated Effective January 25, 2008 Purpose of the Plan Section I - Definitions
12/34/56
EX-10
from 10-K ~10 pages Alpharma Inc. 2007 Supplemental Savings Plan Effective January 1, 2008 Alpharma Inc. 2007 Supplemental Savings Plan Effective January 1, 2008
12/34/56
EX-10
from 10-K ~10 pages Alpharma Inc. 2005 Supplemental Savings Plan Amended and Restated Effective January 1, 2008 Alpharma Inc. 2005 Supplemental Savings Plan Amended and Restated Effective January 1, 2008
12/34/56
EX-10
from 10-K ~20 pages Alpharma Inc. 2003 Omnibus Incentive Compensation Plan
12/34/56
EX-10
from 10-K ~10 pages Service Agreement This Agreement ("Agreement") Made Effective as of December 17, 2007 (The "Effective Date") by and Between Ventiv Commercial Services, LLC, a New Jersey Limited Liability Company ("Ventiv") and Alpharma Pharmaceuticals LLC, a Delaware Limited Liability Company ("Client"). Ventiv and Client May Each Be Referred to Herein as a "Party" and Collectively, the "Parties"
12/34/56
EX-10
from 10-K 1 page "Without Regard to the Occurrence of a Qualifying Transaction (As Defined Below), on January 16, 2008, You Will Receive a Long-Term Incentive Award in the Form of Restricted Stock Units Under the Company's 2003 Omnibus Incentive Compensation Plan (The "Omnibus Plan") Consisting of 10,000 Restricted Stock Units. as You May Know, Restricted Stock Units Are Units That Alpharma Holds for You, Pending the Satisfaction of the Restrictions Set Forth in the Restricted Stock Unit Award Agreement." Alpharma as By: /S/ Mikkel Lyager-Olsen /S/ Frode Johansen /S/ Arnt-Tore Valsvik Mikkel Lyager-Olsen Frode Johansen Arnt-Tore Valsvik Director Chairman Director Dated: January 16, 2008 I Acknowledge and Agree to the Terms and Conditions of This Agreement, and I Intend to Be Legally Bound Hereby
12/34/56
EX-10
from 10-K ~10 pages November 9, 2007 Mr. Carl-Aake Carlsson Batstojordet 93 N-1363 Hovik, Norway Dear Carl-Aake
12/34/56
EX-10.2
from 8-K 8 pages Material contract
12/34/56